MP47-11 CANDIDATE BIOMARKER FOR BONE MORPHOGENETIC PROTEIN 2 PREDICTS RENAL CELL CARCINOMA PROGRESSION VIA ITS PROMOTER CPG HYPERMETHYLATION

2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Yozo Mitsui ◽  
Naoko Arichi ◽  
Miho Hiraki ◽  
Hiroaki Yasumoto ◽  
Shinichiro Fukuhara ◽  
...  
2004 ◽  
Vol 172 (2) ◽  
pp. 475-476 ◽  
Author(s):  
MUTSUSHI YAMASAKI ◽  
TAKEO NOMURA ◽  
HIROMITSU MIMATA ◽  
YOSHIO NOMURA

2008 ◽  
Vol 180 (1) ◽  
pp. 343-351 ◽  
Author(s):  
Ichiro Kagara ◽  
Hideki Enokida ◽  
Kazumori Kawakami ◽  
Ryouichirou Matsuda ◽  
Kazuki Toki ◽  
...  

2008 ◽  
Vol 26 (3) ◽  
pp. 239-245 ◽  
Author(s):  
Marta Vidaurreta ◽  
M. Luisa Maestro ◽  
M. Teresa Sanz-Casla ◽  
Carmen Maestro ◽  
Sara Rafael ◽  
...  

2019 ◽  
Vol 5 (2) ◽  
pp. 16
Author(s):  
Estelle Oertling ◽  
Cacey Peters ◽  
Robert Wood ◽  
Jonathan Silberstein ◽  
Andrew B. Sholl ◽  
...  

The phenomenon of heterotopic bone formation (osseous metaplasia) is defined as an abnormal ossification of non-skeletal tissues and does represent a rare occurrence in the renal cell carcinoma setting. We describe a case of a 40-year old man with bilateral renal cell carcinomas of the histological clear cell subtype, with the right-sided renal cell carcinoma demonstrating heterotopic bone formation, as well as the presence of intratumoral adipose tissue. The etiology of bone formation in a renal cell carcinoma is unclear, but possible explanations include a response to tissue ischemia and the expression of Bone Morphogenetic Protein 2. The detection of these rare morphologic variations is of paramount importance, not to be mistaken as sarcomatoid transformation and renal sinus fat invasion, which would advance the pathologic tumor stage and aggressiveness of the disease. 


2009 ◽  
Vol 181 (4S) ◽  
pp. 106-107
Author(s):  
Ichiro Kagara ◽  
Hideki Enokida ◽  
Katsuhisa Mori ◽  
Kenryu Nishiyama ◽  
Naohiko Seki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document